"Great opportunities" in £2.2 billion UK pathology sector
This article was originally published in Clinica
The reprovisioning of UK National Health Service pathology will offer "the most exciting new opportunities for private and public sector pathology laboratories in the next few years". This is the conclusion of a new report, UK Pathology Markets 2002, from healthcare analysts Laing & Buisson. It maintains that while some change will involve the re-organisation of NHS laboratories, there will also be many opportunities for private-public partnerships with UK and foreign laboratory operators or other pathology-related businesses.